title: T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
abstract: CD95(APO-1 / Fas) ligand (CD95L) gene expression is critically involved in activation-induced T cell apoptosis. We and other have previously shown that HIV-1 Tat which is essential for efficient HIV gene expression sensitizes CD95-mediated apoptosis and up-regulates CD95L expression in T cells. In the present study we have investigated the regulatory mechanism for CD95L expression. Two NF-kappaB binding sites are localized at - 537 to - 521 and - 57 to - 47 (relative to the transcription start site) of the human CD95L promoter. We show that both elements bind to NF-kappaB and SP-1 transcription factors and NF-kappaB is involved in transactivation of the CD95L promoter upon T cell activation. Mutations at each NF-kappaB site by two base pair substitutions resulted in 30 - 70 % reduction of the promoter activity. The effect of Tat on the human CD95L promoter activity was mapped to the same sites. Mutation of each NF-kappaB site also impaired the effect of Tat on CD95L promotor activity. We also show that ectopic expression of Tat protein in Jurkat T cells greatly increases NF-kappaB binding to its target DNA. Our studies provide evidence that Tat-enhanced CD95L expression is regulated at least in part by the NF-kappaB sites of the promoter.
authors.affiliation: Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.li-weber@dkfz-heidelberg.de
authors.forename: M
authors.initials: M
authors.lastname: Li-Weber
authors.forename: O
authors.initials: O
authors.lastname: Laur
authors.forename: K
authors.initials: K
authors.lastname: Dern
authors.forename: P H
authors.initials: PH
authors.lastname: Krammer
mesh_terms: D017209:Apoptosis / Q000235:genetics / Q000276:immunology*; D053222:Fas Ligand Protein; D005786:Gene Expression Regulation / Q000276:immunology; D015696:Gene Products, tat / Q000235:genetics / Q000276:immunology*; D006801:Humans; D019169:Jurkat Cells; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000235:genetics / Q000276:immunology*; D016328:NF-kappa B / Q000235:genetics / Q000276:immunology*; D011401:Promoter Regions, Genetic; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology*; D014158:Transcription, Genetic; D019014:fas Receptor / Q000235:genetics / Q000276:immunology*
chemical_list: C505661:FASLG protein, human; D053222:Fas Ligand Protein; D015696:Gene Products, tat; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D019014:fas Receptor